These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1354071)

  • 1. PET dopamine D2 receptors and susceptibility to methamphetamine psychosis.
    Iyo M
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():652A-653A. PubMed ID: 1354071
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine D2 and serotonin S2 receptors in susceptibility to methamphetamine psychosis detected by positron emission tomography.
    Iyo M; Nishio M; Itoh T; Fukuda H; Suzuki K; Yamasaki T; Fukui S; Tateno Y
    Psychiatry Res; 1993 Dec; 50(4):217-31. PubMed ID: 8177922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D2 receptors in Huntington's disease: positron emission tomography findings and clinical correlates.
    Brandt J; Folstein SE; Wong DF; Links J; Dannals RF; McDonnell-Sill A; Starkstein S; Anders P; Strauss ME; Tune LE
    J Neuropsychiatry Clin Neurosci; 1990; 2(1):20-7. PubMed ID: 1983772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
    Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High central D2-dopamine receptor occupancy as assessed with positron emission tomography in medicated but therapy-resistant schizophrenic patients.
    Coppens HJ; Slooff CJ; Paans AM; Wiegman T; Vaalburg W; Korf J
    Biol Psychiatry; 1991 Apr; 29(7):629-34. PubMed ID: 1675892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of the D2 dopamine receptor in schizophrenia as studied with PET.
    Wiesel FA
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():460A-461A. PubMed ID: 1354050
    [No Abstract]   [Full Text] [Related]  

  • 7. Methamphetamine: toxicity to dopaminergic neurons.
    Seiden LS
    NIDA Res Monogr; 1985; 62():100-16. PubMed ID: 2867472
    [No Abstract]   [Full Text] [Related]  

  • 8. Striatal dopamine D2 receptors in tardive dyskinesia: PET study.
    Blin J; Baron JC; Cambon H; Bonnet AM; Dubois B; Loc'h C; Mazière B; Agid Y
    J Neurol Neurosurg Psychiatry; 1989 Nov; 52(11):1248-52. PubMed ID: 2574230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of dopamine receptors in the neurotoxicity of methamphetamine.
    Ares-Santos S; Granado N; Moratalla R
    J Intern Med; 2013 May; 273(5):437-53. PubMed ID: 23600399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.
    Sekine Y; Iyo M; Ouchi Y; Matsunaga T; Tsukada H; Okada H; Yoshikawa E; Futatsubashi M; Takei N; Mori N
    Am J Psychiatry; 2001 Aug; 158(8):1206-14. PubMed ID: 11481152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers.
    Volkow ND; Fowler JS; Wang GJ; Hitzemann R; Logan J; Schlyer DJ; Dewey SL; Wolf AP
    Synapse; 1993 Jun; 14(2):169-77. PubMed ID: 8101394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET studies of neuroreceptors in schizophrenia. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Wong DF
    Neuropsychopharmacology; 1992 Aug; 7(1):69-72; discussion 73-5. PubMed ID: 1388023
    [No Abstract]   [Full Text] [Related]  

  • 13. A consideration of the dopamine D2 receptor monomer-dimer equilibrium and the anomalous binding properties of the dopamine D2 receptor ligand, N-methyl spiperone.
    Logan J; Fowler JS; Dewey SL; Volkow ND; Gatley SJ
    J Neural Transm (Vienna); 2001; 108(3):279-86. PubMed ID: 11341479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striatal D2 dopaminergic receptor status ascertained in vivo by positron emission tomography and 76Br-bromospiperone in untreated schizophrenics.
    Martinot JL; Huret JD; Peron-Magnan P; Mazoyer BM; Baron JC; Caillard V; Syrota A; Loo H
    Psychiatry Res; 1989 Sep; 29(3):357-8. PubMed ID: 2575262
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of lithium on dopamine D2 receptor expression in the rat brain striatum.
    Kameda K; Miura J; Suzuki K; Kusumi I; Tanaka T; Koyama T
    J Neural Transm (Vienna); 2001; 108(3):321-34. PubMed ID: 11341484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course of D2-dopamine receptor occupancy examined by PET after single oral doses of haloperidol.
    Nordström AL; Farde L; Halldin C
    Psychopharmacology (Berl); 1992; 106(4):433-8. PubMed ID: 1533719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum.
    Andreasen NC; Carson R; Diksic M; Evans A; Farde L; Gjedde A; Hakim A; Lal S; Nair N; Sedvall G
    Schizophr Bull; 1988; 14(3):471-84. PubMed ID: 2975043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential visualization of dopamine D2 and D3 receptors in rat brain.
    Parsons B; Stanley M; Javitch J
    Eur J Pharmacol; 1993 Apr; 234(2-3):269-72. PubMed ID: 8097723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial brain dopamine D2 receptor agonists in the treatment of schizophrenia.
    Coward D; Dixon K; Enz A; Shearman G; Urwyler S; White T; Karobath M
    Psychopharmacol Bull; 1989; 25(3):393-7. PubMed ID: 2576320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Technetium-99m spiperone dithiocarbamate: a potential radiopharmaceutical for dopamine receptor imaging with SPECT.
    Ballinger JR; Gulenchyn KY; Hassan MN
    Int J Rad Appl Instrum A; 1989; 40(6):547-9. PubMed ID: 2551854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.